Valuation (7%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -490.60 | -43.63 |
| PEG Ratio (TTM) | -6.71 | 1.98 |
| P/S Ratio (TTM) | 3.33 | 2.21 |
| P/B Ratio (TTM) | 3.50 | 0.37 |
| P/FCF Ratio (TTM) | 151.62 | 25.44 |
| Price to 5YR AVG Earnings Ratio | N/A | -79.51 |
| Price to 5YR AVG FCF Ratio | N/A | 11.31 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.33% | 2.15% |
| ROE (TTM) | -1.00% | 1.38% |
| Net Profit Margin (TTM) | -0.63% | 4.12% |
| ROIC 5YR AVG | N/A | 0.45% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 346.49% | -0.51% | N/A |
| Revenue | 8.15% | 26.81% | N/A |
| Net Income | 347.98% | -0.65% | N/A |
| Cash Flow | 170.05% | 58.79% | N/A |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.62 | 1.09 |
| Quick Ratio (TTM) | 0.77 | 0.77 |
| D/E Ratio (TTM) | 0.55 | 0.82 |
| Interest Coverage (TTM) | 1.14 | 5.66 |
| Piotroski F-Score | 5 | 5 |
| Altman Z-Score | 2.63 | 1.95 |
| LTL to 5YR AVG FCF | N/A | 0.48 |
| Shares Outstanding Growth 5YR AVG | N/A | 10.18% |